Zura Bio Ltd Banner Image

Zura Bio Ltd

  • Ticker ZURA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Zura Bio Ltd Logo Image
  • 11-50 Employees
  • Based in San Diego, California
Zura Bio Limited is a clinical-stage biotechnology company advancing immunology assets into Phase 2 development programs, including ZB-168 and torudokimab. ZB-168 is an anti IL7R α inhibitor that has the potential to impact diseases driven by IL7 and TSLP biological pathways. Zura aims to develop a portfolio of therapeutic indications for ZB-168 which build on existing Phase 1b data inMore Type 1 Diabetes demonstrating a favorable safety profile and strong biological rationale. Torudokimab is a fully human, high affinity monoclonal antibody that neutralizes IL33 and is currently at the Phase 2 clinical development stage. Zura Bio is headquartered in San Diego, CA with team members in the UK and USA.
Zura Bio Ltd

Most Recent Annual Report

Zura Bio Ltd
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Zura Bio Ltd Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!